Schedule 13G ownership disclosure

ROYALTY PHARMA PLC- CL A

Security class unavailable · CUSIP: G7709Q104

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
29,636,565
Percent of class
6.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-018488
Form type
SC 13G
Filer
Royalty Pharma plc
CIK
CIK 1802768
Filed
Feb 10, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub